AmphiStar Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 30

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $2.91M

  • Investors
  • 9

AmphiStar General Information

Description

Developer of a biosurfactant technology platform designed to aid the transition from a fossil-based to a more environmentally friendly and bio-based industry. The company's production processes are based on industrial biotechnology and use sustainable, renewable raw materials, including biomass feedstocks such as glucose and fatty acids, crude glycerine, and food waste, enabling the healthcare industry to maintain sustainability in biosurfactant production.

Contact Information

Website
www.amphistar.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • VIB BIO-INCUBATOR, Suzanne Tassierstraat 1
  • 9052 Ghent
  • Belgium
Primary Industry
Specialty Chemicals
Vertical(s)
CleanTech, FoodTech, Manufacturing, Climate Tech, Life Sciences
Corporate Office
  • VIB BIO-INCUBATOR, Suzanne Tassierstraat 1
  • 9052 Ghent
  • Belgium

AmphiStar Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AmphiStar Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 09-Jul-2025 $2.91M Completed Generating Revenue
6. Early Stage VC 09-Jul-2025 Completed Generating Revenue
5. Grant 15-Oct-2024 Completed Generating Revenue
4. Early Stage VC 18-Apr-2024 Completed Generating Revenue
3. Grant 01-Jan-2023 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2023 $250K $250K Completed Generating Revenue
1. University Spin-Out 01-Jan-2021 Completed Startup
To view AmphiStar’s complete valuation and funding history, request access »

AmphiStar Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
Ordinary 103,029 $5.39 $5.39 1x $5.39 5.52%
To view AmphiStar’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

AmphiStar Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biosurfactant technology platform designed to aid the transition from a fossil-based to a more environmen
Specialty Chemicals
Ghent, Belgium
30 As of 2026

Birkenhead, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AmphiStar Competitors (1)

One of AmphiStar’s competitors is Holiferm, a Venture Capital-Backed company based in Birkenhead, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Holiferm Venture Capital-Backed Birkenhead, United Kingdom
You’re viewing 1 of 1 competitors. Get the full list »

AmphiStar Patents

  • 13

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 7

    Pending

  • Expiring in next 12 mo

AmphiStar Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4805489-A2 Sble mutants with altered activity and sble homologues Pending 07-Nov-2023
WO-2025099076-A2 Sble mutants with altered activity and sble homologues Inactive 07-Nov-2023
WO-2025099076-A3 Sble mutants with altered activity and sble homologues Inactive 07-Nov-2023
JP-2026010027-A Method for isolating and / or purifying glycolipids Pending 30-Mar-2021
CA-3215734-A1 Process for isolation and/or purifying of glycolipids Pending 30-Mar-2021 C07H15/10
To view AmphiStar’s complete patent history, request access »

AmphiStar Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AmphiStar Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
European Innovation Council Accelerator/Incubator Minority
ECBF VC Venture Capital Minority
Flanders Future Techfund Venture Capital Minority
PMV (Belgium) Asset Manager Minority
Qbic Fund Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

AmphiStar FAQs

  • When was AmphiStar founded?

    AmphiStar was founded in 2021.

  • Where is AmphiStar headquartered?

    AmphiStar is headquartered in Ghent, Belgium.

  • What is the size of AmphiStar?

    AmphiStar has 30 total employees.

  • What industry is AmphiStar in?

    AmphiStar’s primary industry is Specialty Chemicals.

  • Is AmphiStar a private or public company?

    AmphiStar is a Private company.

  • What is AmphiStar’s current revenue?

    The current revenue for AmphiStar is .

  • How much funding has AmphiStar raised over time?

    AmphiStar has raised $18.9M.

  • Who are AmphiStar’s investors?

    European Innovation Council, ECBF VC, Flanders Future Techfund, PMV (Belgium), and Qbic Fund are 5 of 9 investors who have invested in AmphiStar.

  • Who are AmphiStar’s competitors?

    Holiferm is a competitor of AmphiStar.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process